Compulsory Licensing To Cut Drug Costs Could Harm Public
Prescription drug prices, and means by which the executive branch might lower them absent legislative action, were a hot topic during the 2020 election, particularly during the Democratic primary. Multiple candidates...To view the full article, register now.
Already a subscriber? Click here to view full article